LPA Antikörper (Middle Region)

Produktnummer ABIN926447

Produktdetails anti-LPA Antikörper

Target: LPA (APOA) (Apolipoprotein A (APOA))

Bindungsspezifität: Middle Region

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser LPA Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Aufreinigung: Purified

Immunogen: Lp (a) antibody was raised in rabbit using the middle region of LPA as the immunogen

Anwendungsinformationen

Applikationshinweise: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Kommentare:

Lp (a) Blocking Peptide, catalog no. 33R-8931, is also available for use as a blocking control in assays to test for specificity of this Lp (a) antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Details zu LPA

Target: LPA (APOA) (Apolipoprotein A (APOA))

Andere Bezeichnung: Lp (A) (APOA Produkte)

Synonyme: AK38 antikoerper, APOA antikoerper, LP antikoerper, Apo(a) antikoerper, Lp(a) antikoerper, lipoprotein(a) antikoerper, LPA antikoerper

Hintergrund: LPA is a serine proteinase that inhibits the activity of tissue-type plasminogen activator I. The protein constitutes a substantial portion of lipoprotein(a) and is proteolytically cleaved, resulting in fragments that attach to atherosclerotic lesions and promote thrombogenesis. Elevated plasma levels of this protein are linked to atherosclerosis. Depending on the individual, the protein contains 2-43 copies of kringle-type domains. Synonyms: Polyclonal Lp (a) antibody, Anti-Lp (a) antibody, lipoprotein, LPA antibody, LP antibody, AK38 antibody, APOA antibody, LPA antibody.